Joanne Billings, MD, MPH

Assistant Professor of Medicine
Contact Information 
 
Dr. Billings' primary research and clinical work focuses on cystic
fibrosis (CF). She has a particular interest in the women's health issues in patients with CF. Dr. Billings investigates the role of sex hormones in CF and their impact on CF lung disease. Her research examines lung function during the phases of the menstrual cycle in young women with CF. Dr. Billings is also a co-investigator in CF drug development studies at the University.

Current Grant Support

Gilead Science, Inc.  2009-2010
A double blind multi-center multinational randomized placebo-controlled trial evaluating azfreonin lysine for inhalation in patients with cystic fibrosis, mild lung disease and Pseudomonas aeruginosa PLUS expanded access program for aztreonam lysine.

Mpex Pharmaceuticals    2009-2010
A phase 2, multi-center randomized double blind placebo-controlled study to evaluate the safety, tolerability and efficacy of 3 dosage regimens of MP-376 solution for inhalation.  

Transave, Inc.   2007-2009
Multidose safety and tolerability study of liposomal Amikacin

Kalo Bros Pharmaceuticals     2009
A phase I/II randomized double blind placebo-controlled single-dose dose de-escalation study of KB001 in CF patients infected with Pseudomonas aeruginosa.  

Awards
Patient-Oriented Career Development Award 7/2001-6/2006